Paul discusses the need for increased funding for testing and the role of FDA regulations in hindering progress. Tyler raises concerns about Germany's testing strategy and its impact on suppressing the virus. Paul emphasizes the importance of widespread testing, including testing asymptomatic individuals, to effectively identify and control infections.
